331 related articles for article (PubMed ID: 31443309)
21. Current practices in the management of malignant pleural effusions: a survey among members of the European Society of Thoracic Surgeons.
Scarci M; Caruana E; Bertolaccini L; Bedetti B; Brunelli A; Varela G; Papagiannopoulos K; Kuzdzal J; Massard G; Ruffini E; Falcoz PE; Opitz I; Batirel H; Toker A; Rocco G;
Interact Cardiovasc Thorac Surg; 2017 Mar; 24(3):414-417. PubMed ID: 28040756
[TBL] [Abstract][Full Text] [Related]
22. Role of early definitive management for newly diagnosed malignant pleural effusion related to lung cancer.
Chiang KY; Ho JC; Chong P; Tam TC; Lam DC; Ip MS; Lee YG; Lui MM
Respirology; 2020 Nov; 25(11):1167-1173. PubMed ID: 32249488
[TBL] [Abstract][Full Text] [Related]
23. Multiple myeloma with myelomatous pleural effusion: a case report and review of the literature.
Kim YJ; Kim SJ; Min K; Kim HY; Kim HJ; Lee YK; Zang DY
Acta Haematol; 2008; 120(2):108-11. PubMed ID: 18957845
[TBL] [Abstract][Full Text] [Related]
24. Better effect of intrapleural perfusion with hyperthermic chemotherapy by video-assisted thoracoscopic surgery for malignant pleural effusion treatment compared to normothermic chemoperfusion of the pleural cavity.
Cao Y; Zhang Q; Huang Z; Chai Z; Liu J; Wang J; Sun Z; Zhao T; Wang G; Chen G; Han Y; Li Q; Hong X
Cancer Med; 2022 Jan; 11(2):348-357. PubMed ID: 34854253
[TBL] [Abstract][Full Text] [Related]
25. Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma.
Verma A; Chopra A; Lee YW; Bharwani LD; Asmat AB; Aneez DB; Akbar FA; Lim AY; Chotirmall SH; Abisheganaden J
Curr Drug Discov Technol; 2016; 13(2):68-76. PubMed ID: 27216707
[TBL] [Abstract][Full Text] [Related]
26. Recent developments in pleurodesis for malignant pleural disease.
Guinde J; Georges S; Bourinet V; Laroumagne S; Dutau H; Astoul P
Clin Respir J; 2018 Oct; 12(10):2463-2468. PubMed ID: 30252207
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of pleural effusion caused by lung carcinoma with circular intrapleural hyperthermic perfusion and its mechanism].
Kang M; Zhou L; Lin P
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1176-9. PubMed ID: 11769704
[TBL] [Abstract][Full Text] [Related]
28. An Observational Study Evaluating the Performance of LENT Score in the Selected Population of Malignant Pleural Effusion from Lung Adenocarcinoma in Singapore.
Abisheganaden J; Verma A; Dagaonkar RS; Light RW
Respiration; 2018; 96(4):308-313. PubMed ID: 29945142
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and management of malignant pleural effusions.
Heffner JE
Respirology; 2008 Jan; 13(1):5-20. PubMed ID: 18197908
[TBL] [Abstract][Full Text] [Related]
30. Interventional therapies for malignant pleural effusions: the present and the future.
Thomas R; Francis R; Davies HE; Lee YC
Respirology; 2014 Aug; 19(6):809-22. PubMed ID: 24947955
[TBL] [Abstract][Full Text] [Related]
31. Molecular Profiling of Malignant Pleural Effusion in Metastatic Non-Small-Cell Lung Carcinoma. The Effect of Preanalytical Factors.
Carter J; Miller JA; Feller-Kopman D; Ettinger D; Sidransky D; Maleki Z
Ann Am Thorac Soc; 2017 Jul; 14(7):1169-1176. PubMed ID: 28557526
[TBL] [Abstract][Full Text] [Related]
32. Clinical course of asymptomatic malignant pleural effusion in non-small cell lung cancer patients: A multicenter retrospective study.
Roh J; Ahn HY; Kim I; Son JH; Seol HY; Kim MH; Lee MK; Eom JS
Medicine (Baltimore); 2021 May; 100(19):e25748. PubMed ID: 34106603
[TBL] [Abstract][Full Text] [Related]
33. ERS/EACTS statement on the management of malignant pleural effusions.
Bibby AC; Dorn P; Psallidas I; Porcel JM; Janssen J; Froudarakis M; Subotic D; Astoul P; Licht P; Schmid R; Scherpereel A; Rahman NM; Cardillo G; Maskell NA
Eur Respir J; 2018 Jul; 52(1):. PubMed ID: 30054348
[TBL] [Abstract][Full Text] [Related]
34. Animal models of malignant pleural effusion.
Stathopoulos GT; Kalomenidis I
Curr Opin Pulm Med; 2009 Jul; 15(4):343-52. PubMed ID: 19387350
[TBL] [Abstract][Full Text] [Related]
35. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients.
Yang L; Wang F; Wang L; Huang L; Wang J; Zhang B; Zhang Y
Oncotarget; 2015 Apr; 6(12):10592-603. PubMed ID: 25871392
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of medical thoracoscopy in malignant pleural effusion.
Wu YB; Xu LL; Wang XJ; Wang Z; Zhang J; Tong ZH; Shi HZ
BMC Pulm Med; 2017 Aug; 17(1):109. PubMed ID: 28778184
[TBL] [Abstract][Full Text] [Related]
37. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score.
Clive AO; Kahan BC; Hooper CE; Bhatnagar R; Morley AJ; Zahan-Evans N; Bintcliffe OJ; Boshuizen RC; Fysh ET; Tobin CL; Medford AR; Harvey JE; van den Heuvel MM; Lee YC; Maskell NA
Thorax; 2014 Dec; 69(12):1098-104. PubMed ID: 25100651
[TBL] [Abstract][Full Text] [Related]
38. Management of the patient with a malignant pleural effusion.
Heffner JE
Semin Respir Crit Care Med; 2010 Dec; 31(6):723-33. PubMed ID: 21213204
[TBL] [Abstract][Full Text] [Related]
39. Th17 cells and their related cytokines: vital players in progression of malignant pleural effusion.
Niu Y; Zhou Q
Cell Mol Life Sci; 2022 Mar; 79(4):194. PubMed ID: 35298721
[TBL] [Abstract][Full Text] [Related]
40. [Progress of Liquid Biopsy in the Diagnosis and Treatment of Lung Cancer
with Malignant Pleural Effusion].
Zeng H; Tian P; Li W
Zhongguo Fei Ai Za Zhi; 2021 Sep; 24(9):653-659. PubMed ID: 34256901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
